Viekira PAK (ombitasvir, paritaprevir, and ritonavir tablets; dasabuvir tablets), Co-packaged for Oral Use

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)   April 2016 USE IN SPECIFIC POPULATIONS Pregnancy Animal data Ombitasvir Ombitasvir was administered orally to...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts